PMCTPharmaCountry
    ホーム

規制動向

FDA、EMA、TGA および世界の規制動向

#ANDA078940 ×

UPDATED
規制動向
2026年9月22日•1分で読めます
FDA Issues Tentative Approval for Atomoxetine Hydrochloride Capsules (ANDA078940)
The FDA has granted tentative approval for six oral capsule strengths of atomoxetine hydrochloride under ANDA078940, sponsored by Actavis Elizabeth.